Company intelligence / Profile preview

Valeritas

Bridgewater, New Jersey, United Statesveritaglobal.net ↗

Ownership: Private
Development stage: Other

Overview

The V-Go Wearable Insulin Delivery Device was cleared for use in the US and EU. Real-world analyses showed that V-Go lowered A1C with less insulin compared to multiple daily injections. The product enabled simplified basal-bolus insulin management for adults with type 2 diabetes. Other pipeline details are not available.

Therapeutic areas: Metabolic DisordersRare DiseasesEndocrinology
Modalities: DevicePeptide-based therapeutics
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Valeritas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valeritas.

Explore the full profile